ZennCell Receives MFDS Approval for Two Functional Ingredients in General Food Products

Genencell announced on the 15th that its self-developed eye health ingredient and premenstrual syndrome (PMS) improvement ingredient have obtained approval from the Ministry of Food and Drug Safety (MFDS) as raw materials for "functional labeling of general foods."

The two raw materials are the eye health ingredient for aging, ‘CA-HE50,’ and the PMS improvement ingredient, ‘Premensia,’ which completed preclinical trials and human application trials in 2021 and this year, respectively. They received approval as "individually recognized functional raw materials for health functional foods" from the MFDS.

With recognition as raw materials for "functional labeling of general foods" by the MFDS, these ingredients can be blended into general foods and their functionality can be labeled when sold.

A Genencell official stated, "Most of the commercialized raw materials for ‘functional labeling of general foods’ are notification-type ingredients such as red ginseng, dietary fiber, and probiotics," adding, "There are only 10 raw materials that have been self-developed and individually approved."

Existing raw materials have functionalities such as immune enhancement, cholesterol improvement, antioxidant effects, and blood pressure regulation. The ingredients for eye health due to aging and PMS improvement are the first materials approved by Genencell.

Genencell has partnered with domestic food companies to begin developing various general foods using the two raw materials approved for functional labeling of general foods.

The functional labeling system for general foods was established through an MFDS notification in December 2020. It allows foods manufactured using ingredients or components with scientific evidence of benefits to the human body to display and advertise their functionality.

Genencell is focusing on commercializing health functional foods and securing additional individually recognized functional raw materials in the raw material sector. In the pharmaceutical sector, it is conducting clinical trials for a shingles treatment drug.

This content was produced with the assistance of AI translation services.